Lung Cancer

Secretion of certain cytokines is high, but particularly in NSCC it decreases

Published in Clinical Oncology Week, April 14th, 2003

Secretion of certain cytokines is high, but particularly in nonsmall cell lung cancer, it decreases.

According to a study from Croatia, "Lung cancer is one of the most common malignant diseases and is amongst the leading causes of death. Cell-mediated immune response and cytokines could play an important role in antitumor immunity. The aim of the study was to evaluate the cytokine releasing capacity of TNF-alpha, interleukin-1beta (IL-1beta), and IL-6 in patients with lung carcinoma and benign lung disease.

"A group of 41 patients were tested for the production of TNF-alpha, IL-1beta, and IL-6 in broncheoalveolar lavage (BAL) and blood. The levels...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2003-04-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry